In the PAN02 pancreatic cancer model, HMC nanoparticles facilitate tumor cell internalization, triggering robust ROS bursts that promote apoptosis and ICD, evidenced by elevated calreticulin (CRT) exposure, ATP secretion, and reduced nuclear HMGB1 retention. This evidence concerns the gene HMGB1 and neoplasm.